Report on the use of non‐clinical studies in the regulatory evaluation of oncology drugs-Reference-Cited by-同舟云学术

Report on the use of non‐clinical studies in the regulatory evaluation of oncology drugs

Published:2016-02 Issue:2 Volume:107 Page:189-202
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Hayakawa Yoshihiro¹²,Kawada Manabu¹³,Nishikawa Hiroyoshi¹⁴,Ochiya Takahiro¹⁵,Saya Hideyuki¹⁶,Seimiya Hiroyuki¹⁷,Yao Ryoji¹⁸,Hayashi Masahiro¹⁹,Kai Chieko¹¹⁰,Matsuda Akira¹¹¹,Naoe Tomoki¹¹²,Ohtsu Atsushi¹¹³,Okazaki Taku¹¹⁴,Saji Hideo¹¹⁵,Sata Masataka¹¹⁶,Sugimura Haruhiko¹¹⁷,Sugiyama Yuichi¹¹⁸,Toi Masakazu¹¹⁹,Irimura Tatsuro¹²⁰

Affiliation:

1. Subcommittee on Non‐clinical Studies The Science Board to the Pharmaceuticals and Medical Devices Agency TokyoJapan

2. Division of Pathogenic Biochemistry Department of Bioscience Institute of Natural Medicine University of Toyama ToyamaJapan

3. Institute of Microbial Chemistry Microbial Chemistry Research Foundation Numazu‐shiJapan

4. Division of Cancer Immunology Exploratory Oncology Research and Clinical Trial Center National Cancer Center ChibaJapan

5. Division of Molecular and Cellular Medicine National Cancer Center Research Institute TokyoJapan

6. Division of Gene Regulation Institute for Advanced Medical Research School of Medicine Keio University TokyoJapan

7. Division of Molecular Biotherapy Cancer Chemotherapy Center Japanese Foundation for Cancer Research TokyoJapan

8. Division of Cell Biology Cancer Institute Japanese Foundation for Cancer Research TokyoJapan

9. Department of Pharmacy Toranomon Hospital TokyoJapan

10. Laboratory Animal Research Center Institute of Medical Science The University of Tokyo TokyoJapan

11. Department of Medicinal Chemistry Faculty of Pharmaceutical Sciences Hokkaido University SapporoJapan

12. National Hospital Organization Nagoya Medical Center NagoyaJapan

13. Exploratory Oncology Research and Clinical Trial Center National Cancer Center ChibaJapan

14. Division of Immune Regulation Institute for Genome Research Tokushima University TokushimaJapan

15. Department of Patho‐Functional Bioanalysis, Graduate School of Pharmaceutical Sciences Kyoto University KyotoJapan

16. Department of Cardiovascular Medicine Institute of Biomedical Sciences Tokushima University Graduate School TokushimaJapan

17. Department of Tumor Pathology Hamamatsu University School of Medicine ShizuokaJapan

18. Sugiyama Laboratory RIKEN Innovation Center RIKEN Cluster for Industry Partnerships KanagawaJapan

19. Department of Breast Surgery Graduate School of Medicine Kyoto University KyotoJapan

20. Juntendo University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12857

Reference97 articles.

1. DNA and its associated processes as targets for cancer therapy

2. A History of Cancer Chemotherapy

3. Targeting tumour-supportive cellular machineries in anticancer drug development

4. Cellular Oncogenes and Multistep Carcinogenesis

5. Tumor Suppressor Genes: New Prospects for Cancer Research

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation status of pharmacological studies in the development of orphan drugs;Orphanet Journal of Rare Diseases;2024-01-02

2. Implementation status of pharmacological studies in the development of orphan drugs;2023-09-05

3. Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma;Molecular Cancer Research;2023-07-26

4. Landscape of Manufacturing Process of ATMP Cell Therapy Products for Unmet Clinical Needs;Stem Cells in Clinical Practice and Tissue Engineering;2018-05-02

5. Current state of therapeutic development for rare cancers in Japan, and proposals for improvement;Cancer Science;2018-05